Posted by Michael Wonder on 11 Aug 2023
PHARMAC proposes widening access to a brain cancer treatment to help reduce the impact of a discontinuation
11 August 2023 - PHARMAC is proposing to widen access to temozolomide, an oral anti-cancer treatment, for people with a type of brain cancer called glioma.
This comes as lomustine, the current treatment option for people with low grade or relapsed/recurrent gliomas is being discontinued.
